Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> RECKITT BENCKISER Latest News

NOV 17, 2014 - Wall Street Journal

A Must Read - Share

Reckitt Benckiser Announces Indivior Float

Reckitt Benckiser said it expects its pharmaceutical unit—Indivior—to start trading on the London Stock Exchange on Dec. 23.

Tags: Reckitt Benckiser Announces Indivior Float,  Reckitt Benckiser Latest News

NOV 17, 2014 - The Independent

A Must Read - Share

Reckitt Benckiser to float drug treatment unit in London

Reckitt Benckiser, the maker of Nurofen and Strepsils, will float its drug addiction treatment business on the London Stock Exchange before Christmas to create a company that could be worth more than £2.5 billion.

Tags: Reckitt Benckiser to float drug treatment unit in London,  Reckitt Benckiser Latest News

NOV 17, 2014 - New York Times

A Must Read - Share

DealBook: Reckitt Benckiser Plans December Spinoff of Pharmaceutical Arm

If the spinoff is approved by shareholders, the stand-alone drug business would be called Indivior and begin trading on the London Stock Exchange on Dec. 23.

Tags: DealBook: Reckitt Benckiser Plans December Spinoff of Pharmaceutical Arm,  Reckitt Benckiser Latest News

NOV 17, 2014 - DealBook

A Must Read - Share

Reckitt Benckiser Plans December Spinoff of Pharmaceutical Arm

If the spinoff is approved by shareholders, the stand-alone drug business would be called Indivior and begin trading on the London Stock Exchange on Dec. 23.

Tags: Reckitt Benckiser Plans December Spinoff of Pharmaceutical Arm,  Reckitt Benckiser Latest News

NOV 17, 2014 - Wall Street Journal

A Must Read - Share

Reckitt Benckiser Details Indivior Float

Reckitt Benckiser said it expects its pharmaceutical unit—Indivior—to start trading on the London Stock Exchange on Dec. 23.

Tags: Reckitt Benckiser Details Indivior Float,  Reckitt Benckiser Latest News